Abstract
Background: The improvements in HIV infection therapy and the large availability of antiretroviral drugs have led to an increased survival among HIV infected people, and simultaneously to a raised morbidity and mortality due to not-AIDS-related events in this group compared to the general population. An increased systemic inflammation and a persistent immune activation play a pivotal role in determining high rates of non-AIDS comorbidities. In the last years, many natural or synthetic immunomodulatory molecules acting by different mechanisms have been conceived. Pidotimod is a synthetic dipeptide molecule showing immunomodulatory properties. The aim of this pilot study was to evaluate the effects of Pidotimod supplementation on residual inflammation in HIV infected population.
Methods: Forty HIV positive individuals under cART were enrolled: 30 were treated with Pidotimod supplementation (study group) and 10 served as control group (without Pidotimod supplementation). For all participants, Cystatin C, PCR, ESR, microalbuminuria, TNF-α, INF-γ, IL-4, IL-10, IL1β, IL-18 and IL-2 were measured at enrolment (T0), 4 weeks after of Pidotimod supplementation (T1), and 4 weeks after completing supplementation (T2). Results: In HIV positive participants treated with Pidotimod, the evaluation of cytokine levels showed that IL-10, IFN gamma, and IL-4 were significantly higher at enrolment compared to the control group. The increase under Pidotimod treatment persisted after supplementation suspension, while the pro-inflammatory cytokines levels were reduced. Salivary IgA also increased during 4 weeks of supplementation and persisted at 4 weeks after completing supplementation. On the other hand, the Cystatin C and microalbuminuria levels decreased over time, at a greater extent the Cystatin C serum levels. Conclusion: The study findings showed that the HIV population receiving Pidotimod achieved a rebalancing of pro-inflammatory and anti-inflammatory cytokines as well as a significant reduction in cystatin C levels. The treatment further allowed for an increase in salivary IgA levels at all the analyzed times, as a secondary event to a remodulation of the immunological status obtained with pidotimod. This approach could represent a new way to design new intervention strategies aimed at improving the persistent immune activation status in the virologically suppressed HIV population.Keywords: Supplementation, AIDS, cytokines, immunostimulatory, inflammation, immunological rebalancing.
Graphical Abstract
[http://dx.doi.org/10.1371/journal.pone.0081355] [PMID: 24367482]
[http://dx.doi.org/10.1093/ije/dyr164] [PMID: 22493325]
[http://dx.doi.org/10.2174/1570162X18666200609115615] [PMID: 32516101]
[http://dx.doi.org/10.1186/s12882-017-0672-9] [PMID: 28754089]
[http://dx.doi.org/10.1007/s11904-017-0356-x] [PMID: 28434169]
[http://dx.doi.org/10.1212/WNL.0b013e318200d727] [PMID: 21135382]
[http://dx.doi.org/10.2174/157016210791330365] [PMID: 20426756]
[http://dx.doi.org/10.1089/aid.2016.0138] [PMID: 27615271]
[PMID: 28534890]
[http://dx.doi.org/10.1016/j.bjid.2015.08.012] [PMID: 26477384]
[http://dx.doi.org/10.1007/s11904-012-0121-0] [PMID: 22618079]
[http://dx.doi.org/10.1097/QAI.0b013e318186519c] [PMID: 18725816]
[http://dx.doi.org/10.2174/1570162X17666191212091618] [PMID: 31830884]
[http://dx.doi.org/10.1016/S0140-6736(08)60423-7] [PMID: 18387667]
[http://dx.doi.org/10.1111/j.1468-1293.2009.00751.x] [PMID: 19682101]
[http://dx.doi.org/10.1016/j.bjid.2016.02.002] [PMID: 26971833]
[http://dx.doi.org/10.1002/jmv.23543] [PMID: 23508901]
[http://dx.doi.org/10.1056/NEJMc071419] [PMID: 17699825]
[http://dx.doi.org/10.1111/hiv.12789] [PMID: 31424619]
[http://dx.doi.org/10.1097/QAD.0b013e32833ef79d] [PMID: 20827169]
[http://dx.doi.org/10.1161/JAHA.116.003371] [PMID: 27353609]
[http://dx.doi.org/10.3390/v12050489] [PMID: 32349381]
[http://dx.doi.org/10.1016/j.thromres.2012.12.007] [PMID: 23290306]
[http://dx.doi.org/10.1017/S0007114515004043] [PMID: 26548336]
[http://dx.doi.org/10.3390/nu7105396] [PMID: 26426044]
[http://dx.doi.org/10.1016/j.clnesp.2016.03.002] [PMID: 28531643]
[http://dx.doi.org/10.2174/1570162X18666200817111152] [PMID: 32807057]
[http://dx.doi.org/10.1186/1824-7288-39-75] [PMID: 24314100]
[http://dx.doi.org/10.1186/s40248-019-0195-2] [PMID: 31700623]
[http://dx.doi.org/10.3389/fphar.2019.01115] [PMID: 31632269]
[http://dx.doi.org/10.3109/08923979209009231] [PMID: 1294620]
[http://dx.doi.org/10.1016/j.intimp.2009.08.010] [PMID: 19712757]
[http://dx.doi.org/10.1016/j.pupt.2017.03.005] [PMID: 28302543]
[http://dx.doi.org/10.23736/S0026-4946.20.05967-8]
[http://dx.doi.org/10.1080/14787210.2019.1679118] [PMID: 31603361]
[http://dx.doi.org/10.1186/s12967-015-0649-z] [PMID: 26335787]
[http://dx.doi.org/10.4084/mjhid.2020.048] [PMID: 32670526]
[http://dx.doi.org/10.1016/S2055-6640(20)30010-8] [PMID: 32175091]
[http://dx.doi.org/10.1186/s12948-015-0012-1] [PMID: 25999796]
[http://dx.doi.org/10.1016/S2352-4642(17)30101-3] [PMID: 30169172]
[http://dx.doi.org/10.1186/s12979-017-0107-2] [PMID: 29387135]
[PMID: 8625781]
[http://dx.doi.org/10.1053/j.semdp.2017.04.002] [PMID: 28552209]
[http://dx.doi.org/10.7448/IAS.18.1.20052] [PMID: 26130226]
[http://dx.doi.org/10.1089/aid.2019.0064] [PMID: 31407605]
[http://dx.doi.org/10.1371/journal.ppat.1004078] [PMID: 24831517]
[http://dx.doi.org/10.1093/cid/cix466] [PMID: 28903507]
[http://dx.doi.org/10.1038/sj.bmt.1701604] [PMID: 10100562]
[http://dx.doi.org/10.1016/S2352-3018(15)00006-5] [PMID: 26424550]
[PMID: 26700083]
[http://dx.doi.org/10.1097/QAD.0000000000000545] [PMID: 25630041]
[http://dx.doi.org/10.1097/00002030-199610000-00006] [PMID: 8902063]
[http://dx.doi.org/10.1080/17512433.2019.1605902] [PMID: 31017494]
[http://dx.doi.org/10.1128/JVI.01690-18] [PMID: 30814287]
[http://dx.doi.org/10.1002/cncy.22097] [PMID: 30661307]
[http://dx.doi.org/10.1111/hiv.12344] [PMID: 26611175]
[http://dx.doi.org/10.1016/1043-6618(92)90662-U] [PMID: 1409308]
[http://dx.doi.org/10.3390/ijms20215287] [PMID: 31653015]
[PMID: 7531977]
[http://dx.doi.org/10.1081/JAS-120026085] [PMID: 15260461]
[http://dx.doi.org/10.1016/j.intimp.2018.11.043] [PMID: 30530167]
[PMID: 16501238]
[http://dx.doi.org/10.3851/IMP1809] [PMID: 21817185]
[http://dx.doi.org/10.1002/rmv.1933] [PMID: 28573797]
[http://dx.doi.org/10.1111/jop.12061] [PMID: 23551639]
[http://dx.doi.org/10.1056/NEJMoa043161] [PMID: 15901858]
[http://dx.doi.org/10.1038/s41467-020-17636-0] [PMID: 32732919]
[http://dx.doi.org/10.1053/j.ajkd.2010.05.019] [PMID: 20709438]
[http://dx.doi.org/10.1093/infdis/jiaa433] [PMID: 32691827]
[http://dx.doi.org/10.1111/hiv.12268] [PMID: 25990642]